Johanna Mylet
Director of Finance/CFO at POSEIDA THERAPEUTICS, INC.
Net worth: 785 643 $ as of 2024-03-30
Profile
Johanna M.
Mylet is currently the Chief Financial Officer at Poseida Therapeutics, Inc. She started this position in 2021.
Prior to her current role, she worked as a Controller at HUYA Bioscience International LLC from 2014 to 2015.
Before that, she served as an Audit Manager at Grant Thornton LLP from 2008 to 2014.
Ms. Mylet completed her undergraduate degree at the University of San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-29 | 246,283 ( 0.26% ) | 785 643 $ | 2024-03-30 |
Johanna Mylet active positions
| Companies | Position | Start |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Director of Finance/CFO | 2020-06-30 |
Former positions of Johanna Mylet
| Companies | Position | End |
|---|---|---|
HUYA Bioscience International LLC
 HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Comptroller/Controller/Auditor | 2015-05-31 |
Grant Thornton LLP
 Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Grant Thornton LLP provides accounting, tax and business consulting services. It offers advisory, business consulting, business risk, enterprise technology and innovation, transaction services, data analytics, cyber risk, and data integrity services. The firm serves the construction, real estate and hospitality, consumer and industrial products, energy, financial services, health care and life sciences, not for profit organizations, private equity, public sector, and technology industries. The company was founded in 1924 and is headquartered in Chicago, IL. | Comptroller/Controller/Auditor | 2014-03-31 |
Training of Johanna Mylet
| University of San Diego | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
HUYA Bioscience International LLC
HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA. | Health Technology |
Grant Thornton LLP
Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Grant Thornton LLP provides accounting, tax and business consulting services. It offers advisory, business consulting, business risk, enterprise technology and innovation, transaction services, data analytics, cyber risk, and data integrity services. The firm serves the construction, real estate and hospitality, consumer and industrial products, energy, financial services, health care and life sciences, not for profit organizations, private equity, public sector, and technology industries. The company was founded in 1924 and is headquartered in Chicago, IL. | Commercial Services |
- Stock Market
- Insiders
- Johanna Mylet
